26
Thu, Dec
48 New Articles

Schoenherr Advises InPharm Co on Acquisition of Casa Spadijer Bioclinica

Serbia
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Moravcevic Vojnovic and Partners in cooperation with Schoenherr has advised InPharm Co on its acquisition of Casa Spadijer Bioclinica.

InPharm Co is a Serbian producer and distributor of dietary supplements, medical products, and cosmetics. In 2023, it joined the Luxembourg-based Sun Wave Group which is also present in Moldova, Romania, Bulgaria, Bosnia and Herzegovina, Montenegro, and Albania.

Founded in Belgrade in 1999, Casa Spadijer Bioclinica is a dietary supplements company.

The Schoenherr team included Partners Vojimir Kurtic and Matija Vojnovic, Attorney at Law Bojan Rajic, and Associates Luka Milosevic, Zeljko Loci, and Stefan Dobras.

Schoenherr did not respond to our inquiry on the matter.

Serbia Knowledge Partner

SOG in cooperation with Kinstellar is a full-service business law firm in Serbia that provides foreign and domestic clients with premium-quality legal advice and assistance across a wide range of key areas of corporate law. The firm was founded in 2015 by a group of seasoned, internationally-trained lawyers. SOG has developed a distinctively dynamic culture, bringing together top talent, fostering entrepreneurship, and maintaining exceptional relationships with its clients.

SOG has achieved consistent growth in the volume of its business, accompanied by an exponential increase in the number of hired associate lawyers and the firm’s network of business contacts. SOG has a robust client base of multinationals, investment and private equity firms, and financial institutions. Clients praise SOG for being commercially minded, very responsive and knowledgeable.

Establishing permanent cooperation with Kinstellar is part of realising SOG's long-term development strategy to be the leading provider of legal services in the Western Balkans market.

Firm's website: https://www.kinstellar.com/

 

Our Latest Issue